Management of Severe Pelvic Inflammatory Disease

Treatment Regimens

• The CDC recommends cefoxitin 2g IM as a single dose or ceftriaxone 500mg IM as a single dose, plus doxycycline 100mg orally twice daily for 14 days, with metronidazole 500mg orally twice daily for 14 days for severe PID requiring outpatient management 1
• For severe PID, the CDC also recommends clindamycin 900mg IV every 8 hours, plus gentamicin loading dose IV or IM (2mg/kg) followed by maintenance dose (1.5mg/kg) every 8 hours, continued for at least 48 hours after clinical improvement, then transitioned to oral therapy 1
• Parenteral therapy should be continued for at least 24-48 hours after clinical improvement, followed by completion of a total of 10-14 days of therapy (IV plus oral) 2, 1
• The CDC recommends treatment with either cefoxitin 2g IV every 6 hours or cefotetan 2g IV every 12 hours plus doxycycline 100mg orally/IV every 12 hours, OR clindamycin 900mg IV every 8 hours plus gentamicin loading dose of 2mg/kg followed by maintenance dose of 1.5mg/kg every 8 hours for hospitalized patients with PID 1
• Patients should receive doxycycline 100mg orally twice daily to complete 10-14 days total after discharge, or alternatively, clindamycin 450mg orally 4 times daily for 10-14 days 1
• Inadequate duration of therapy can lead to treatment failure, and a full 10-14 days of total antibiotic treatment is recommended 1, 3

Patient Selection for Outpatient Management

• Outpatient treatment may be considered for patients with severe PID who can tolerate oral medications, have clinical follow-up within 72 hours, have no surgical emergencies, no suspected pelvic abscess, and are not pregnant 1
• Hospitalization is particularly recommended in situations such as uncertain diagnosis, surgical emergencies, pelvic abscess, pregnancy, adolescence, severe illness, inability to tolerate outpatient regimen, failed outpatient therapy, or inability to arrange clinical follow-up within 72 hours 1

Partner Treatment and Follow-up

• Sex partners of patients with PID should be referred for evaluation and empirically treated with regimens effective against C. trachomatis and N. gonorrhoeae 1
• Patients with PID should be reevaluated within 72 hours to ensure clinical improvement 1
• Patients should be reevaluated to ensure resolution of infection, and clinical follow-up within 72 hours should be arranged 1

Coverage Requirements and Hospitalization

• Any regimen for PID must cover C. trachomatis, N. gonorrhoeae, anaerobes, gram-negative rods, and streptococci 1
• The American College of Obstetricians and Gynecologists recommends transitioning to Clindamycin 450 mg orally four times daily to complete 10-14 days of total therapy after clinical improvement with IV therapy 2

Long-term Sequelae

• The efficacy of outpatient management for preventing long-term sequelae remains uncertain, and outpatient regimens may provide less complete antimicrobial coverage for a shorter duration than inpatient regimens, potentially increasing the risk of long-term complications such as infertility, ectopic pregnancy, and chronic pelvic pain 1
• HIV-infected patients should receive the same treatment regimen as HIV-negative patients, but with closer monitoring due to the potential for more severe and refractory infections 1

Treatment of Pelvic Abscesses

• The CDC recommends Cefoxitin 2 g IV every 6 hours or Cefotetan 2 g IV every 12 hours, plus Doxycycline 100 mg orally or IV every 12 hours for the treatment of cervical abscesses 1, 3
• An alternative regimen is Clindamycin 900 mg IV every 8 hours plus Gentamicin loading dose 2 mg/kg followed by maintenance dose 1.5 mg/kg every 8 hours, providing superior coverage for anaerobic bacteria 1
• The following table summarizes the recommended parenteral regimens for pelvic abscess treatment:

• For patients with inadequate source control, Ertapenem 1 g every 24 hours or Eravacycline 1 mg/kg every 12 hours are recommended 3
• For patients in septic shock, Meropenem 1 g every 6 hours by extended infusion or continuous infusion, or Doripenem 500 mg every 8 hours by extended infusion or continuous infusion, or Imipenem/cilastatin 500 mg every 6 hours by extended infusion, or Eravacycline 1 mg/kg every 12 hours can be used 3
• Antibiotics alone may be insufficient for treatment, and surgical drainage or image-guided drainage should be considered if there is no clinical improvement within 72 hours of initiating antibiotic therapy, or if the abscess is large or well-defined 4, 1
• Failure to consider surgical drainage can result in inadequate treatment, and antibiotics alone may be insufficient for larger abscesses 1
• After clinical improvement with IV therapy, patients can be switched to oral antibiotics such as Doxycycline 100 mg orally twice daily or Clindamycin 450 mg orally 4 times daily to complete 10-14 days of treatment 1